Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Rytz (Bern, Switzerland), A. Poellinger (Bern, Switzerland), S. Berezowska (Bern, Switzerland), T. Geiser (Bern, Switzerland), M. Funke-Chambour (Bern, Switzerland). Pirfenidone as a treatment for asbestos-related lung fibrosis? A retrospective case series. 2993

Member's Comments

No comment yet.

Related content which might interest you: A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis Source: ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020 Year: 2020 Is lung function worsening during adolescence in cystic fibrosis? A retrospective study Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012 A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases; preliminary results. Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 32: 170-174 Year: 2008 Pirfenidone treatment in idiopathic pulmonary fibrosis: An Italian case series Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Multidisciplinary diagnosis of interstitial lung disease: a retrospective analysis Source: International Congress 2019 – Medical education Year: 2019 A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases. Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study Source: Eur Respir J, 54 (1) 1900103; 10.1183/13993003.00103-2019 Year: 2019 Prospective study of feasibility and safety of bronchoscopic transbronchial cryprobe biopsies in interstitial lung disease: Initial experience of an Irish interstitial lung disease centre Source: International Congress 2015 – New insights into IIPs Year: 2015 Longitudinal assessment in combined pulmonary fibrosis and emphysema (CPFE): a case series Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 A retrospective clinical review of drug induced interstitial lung disease at a tertiary cancer centre Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis: a systematic review Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 LATE-BREAKING ABSTRACT: Role of trans-bronchial lung cryobiopsies in interstitial lung diseases: Preliminary results of a Belgian prospective study Source: International Congress 2016 – IPF clinical Year: 2016 Pirfenidone in patients with advanced idiopathic pulmonary fibrosis: First experience Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting Source: International Congress 2014 – ILDs 6 Year: 2014 Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review Source: Eur Respir Rev, 29 (157) 190158; 10.1183/16000617.0158-2019 Year: 2020 Treatment dilemmas in sarcoidosis - a retrospective cohort study Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013